1. Home
  2. ABVX vs RCAT Comparison

ABVX vs RCAT Comparison

Compare ABVX & RCAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABVX
  • RCAT
  • Stock Information
  • Founded
  • ABVX 2013
  • RCAT 2002
  • Country
  • ABVX France
  • RCAT United States
  • Employees
  • ABVX N/A
  • RCAT N/A
  • Industry
  • ABVX
  • RCAT Wholesale Distributors
  • Sector
  • ABVX
  • RCAT Industrials
  • Exchange
  • ABVX Nasdaq
  • RCAT Nasdaq
  • Market Cap
  • ABVX 722.3M
  • RCAT 850.5M
  • IPO Year
  • ABVX N/A
  • RCAT 2017
  • Fundamental
  • Price
  • ABVX $8.08
  • RCAT $7.76
  • Analyst Decision
  • ABVX Strong Buy
  • RCAT Strong Buy
  • Analyst Count
  • ABVX 7
  • RCAT 1
  • Target Price
  • ABVX $37.86
  • RCAT $4.00
  • AVG Volume (30 Days)
  • ABVX 162.8K
  • RCAT 7.7M
  • Earning Date
  • ABVX 03-24-2025
  • RCAT 03-17-2025
  • Dividend Yield
  • ABVX N/A
  • RCAT N/A
  • EPS Growth
  • ABVX N/A
  • RCAT N/A
  • EPS
  • ABVX N/A
  • RCAT N/A
  • Revenue
  • ABVX $9,676,417.00
  • RCAT $16,468,647.00
  • Revenue This Year
  • ABVX $31.67
  • RCAT $113.68
  • Revenue Next Year
  • ABVX $759.77
  • RCAT $206.40
  • P/E Ratio
  • ABVX N/A
  • RCAT N/A
  • Revenue Growth
  • ABVX 100.87
  • RCAT 95.46
  • 52 Week Low
  • ABVX $5.50
  • RCAT $0.69
  • 52 Week High
  • ABVX $17.02
  • RCAT $15.27
  • Technical
  • Relative Strength Index (RSI)
  • ABVX 75.42
  • RCAT 38.28
  • Support Level
  • ABVX $5.88
  • RCAT $8.60
  • Resistance Level
  • ABVX $7.57
  • RCAT $9.69
  • Average True Range (ATR)
  • ABVX 0.46
  • RCAT 0.92
  • MACD
  • ABVX 0.24
  • RCAT -0.17
  • Stochastic Oscillator
  • ABVX 97.68
  • RCAT 0.72

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. They are evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two most common forms are UC and CD.

About RCAT Red Cat Holdings Inc.

Red Cat Holdings Inc is a military technology company that integrates robotic hardware and software to provide critical situational awareness and actionable intelligence to on-the-ground warfighters and battlefield commanders. Its mission is to enhance the effectiveness and safety of military operations domestically and globally. Red Cat's suite of solutions includes Teal Drones, developer of the Golden Eagle, a small unmanned system with the highest resolution imaging for night-time operations, and Skypersonic, a provider of unmanned aircraft for interior spaces and other dangerous environments.

Share on Social Networks: